Amedisys (NASDAQ:AMED) Receives “Equal Weight” Rating from Stephens

Stephens reiterated their equal weight rating on shares of Amedisys (NASDAQ:AMED) in a research note published on Wednesday morning,Benzinga reports. They currently have a $101.00 price objective on the health services provider’s stock.

Amedisys Stock Up 0.2 %

AMED opened at $92.66 on Wednesday. Amedisys has a 1 year low of $82.15 and a 1 year high of $98.95. The firm has a 50 day moving average price of $89.82 and a 200 day moving average price of $93.69. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The company has a market cap of $3.03 billion, a PE ratio of 36.77, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73.

Hedge Funds Weigh In On Amedisys

A number of hedge funds have recently made changes to their positions in AMED. Blue Trust Inc. increased its holdings in Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 124 shares in the last quarter. Xponance Inc. boosted its position in shares of Amedisys by 3.5% in the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider’s stock worth $395,000 after buying an additional 148 shares during the period. Inspire Investing LLC grew its stake in shares of Amedisys by 3.6% in the fourth quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider’s stock valued at $400,000 after buying an additional 155 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Amedisys by 1.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider’s stock valued at $1,375,000 after buying an additional 180 shares in the last quarter. Finally, Retirement Systems of Alabama raised its holdings in shares of Amedisys by 0.5% during the 4th quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider’s stock valued at $3,615,000 after buying an additional 181 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.